SOBRsafe Inc. Reports Significant Revenue Growth Driven by SOBRsure(TM) GEN 2 Sales
SOBRsafe Inc. (NASDAQ: SOBR) achieved a 92.3% year-over-year revenue growth in Q2 2025, largely due to strong sales of its SOBRsure(TM) GEN 2 technology, marking a significant milestone in the company's expansion and innovation in alcohol monitoring solutions.
SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in next-generation alcohol monitoring and detection technology, has announced a remarkable 92.3% year-over-year increase in its Q2 2025 revenue, reaching $104,200. This growth is primarily attributed to the robust sales of its SOBRsure(TM) GEN 2 hardware and software, which accounted for 76.5% of the total revenue. The company also reported a 380 basis points improvement in gross margin, which rose to 57.5%, and a reduction in net loss to $2.0 million from $2.1 million in the same quarter the previous year.
The second quarter of 2025 saw SOBRsafe shipping 178 SOBRsure(TM) GEN 2 devices, a 35.9% increase from Q1. Additionally, the company experienced a 109.6% year-over-year growth in annual recurring software subscription revenue, which now constitutes 55.2% of the quarterly revenue. These figures underscore the growing demand for SOBRsafe's innovative solutions in the market.
Operational milestones during the quarter included the independent third-party validation of the SOBRsure(TM) GEN 2's performance, the launch of an upgraded B2B e-commerce platform, and the issuance of a European Patent for SOBRcheck(TM). Furthermore, SOBRsafe expanded its sales team and made its foray into the Family Law market, signaling its commitment to broadening its market reach and enhancing its product offerings.
As of June 30, 2025, SOBRsafe reported cash and equivalents of $8.5 million, providing the company with a solid foundation to support its ongoing growth initiatives. For more details on SOBRsafe's Q2 2025 performance, visit https://ibn.fm/V6ahv.
SOBRsafe's advanced transdermal technology represents a significant leap forward in alcohol detection, offering a passive, dignified screening solution that requires no breath, blood, or urine samples. This technology, coupled with a powerful backend data platform, positions SOBRsafe as a leader in the behavioral health, family law, and consumer markets. To explore more about SOBRsafe and its innovative solutions, visit https://www.sobrsafe.com.